Company Presentation • 19 Nov 2025 05:00
Company Presentation • 20 Jun 2025 18:00
Company Presentation • 07 Oct 2024 19:00
Company Presentation • 22 Nov 2024 20:00
No more presentations
Search or
𝛼SK
𝛼SKENTITY
IO Biotech Inc (IOBT US)
IO Biotech Inc (IOBT US)
1
Analysis
Health Care • United States
IO Biotech, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing novel, immune-modulating cancer therapies based on our T-win technology platform to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech serves customers in Denmark.
morex